Vicapsys Life Sciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vicapsys Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • Vicapsys Life Sciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$199K, a 13.4% decline year-over-year.
  • Vicapsys Life Sciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.11M, a 9.32% decline year-over-year.
  • Vicapsys Life Sciences, Inc. annual Operating Income (Loss) for 2023 was -$1.05M, a 6.32% decline from 2022.
  • Vicapsys Life Sciences, Inc. annual Operating Income (Loss) for 2022 was -$985K, a 192% decline from 2021.
  • Vicapsys Life Sciences, Inc. annual Operating Income (Loss) for 2021 was -$337K, a 56% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.11M -$199K -$23.4K -13.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-01-10
Q2 2024 -$1.09M -$182K -$46.1K -34% Apr 1, 2024 Jun 30, 2024 10-Q 2025-01-10
Q1 2024 -$1.04M -$204K +$7.02K +3.32% Jan 1, 2024 Mar 31, 2024 10-Q 2025-01-10
Q4 2023 -$1.05M -$525K -$32K -6.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-10-21
Q3 2023 -$1.01M -$175K -$30.3K -20.9% Jul 1, 2023 Sep 30, 2023 10-Q 2025-01-10
Q2 2023 -$985K -$136K +$44.4K +24.6% Apr 1, 2023 Jun 30, 2023 10-Q 2025-01-10
Q1 2023 -$1.03M -$211K -$44.2K -26.5% Jan 1, 2023 Mar 31, 2023 10-Q 2025-01-10
Q4 2022 -$985K -$493K -$389K -374% Oct 1, 2022 Dec 31, 2022 10-K 2024-10-21
Q3 2022 -$596K -$145K -$33.9K -30.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$562K -$180K -$108K -150% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$454K -$167K -$117K -236% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$337K -$104K -$23.3K -28.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$314K -$111K -$22K -24.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$292K -$72.1K +$160K +68.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$451K -$49.8K +$315K +86.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$766K -$80.5K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$89.2K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$232K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-20
Q1 2020 -$364K Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.